M. Pardo

发表

Virus‐specific T‐cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection

V. Carreño, I. Castillo, J. Quiroga, 2006, Journal of medical virology.

Cellular Immune Responses Associated with Occult Hepatitis C Virus Infection of the Liver

V. Carreño, I. Castillo, J. Quiroga, 2006, Journal of Virology.

Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment.

J. Bartolomé, V. Carreño, I. Castillo, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus.

V. Carreño, J. Quiroga, M. Pardo, 1999, The Journal of infectious diseases.

Association of HLA-DR genes with mild idiopathic adulthood biliary ductopenia

V. Carreño, J. Quiroga, M. Pardo, 2001 .

Multicenter randomized study comparing initial daily induction with high dose lymphoblastoid interferon vs. standard interferon treatment for chronic hepatitis C.

M. Diago, V. Carreño, J. Quiroga, 2001, Journal of medical virology.

Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels.

O. Weiland, G. Leroux-Roels, D. Subirá, 2002, Journal of hepatology.

Hepatitis B virus–specific T‐cell proliferation and cytokine secretion in chronic hepatitis B e antibody–positive patients treated with ribavirin and interferon alfa

D. Subirá, S. Castañón, V. Carreño, 2001 .

Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-α

V. Carreño, J. Quiroga, M. Pardo, 1994, Digestive Diseases and Sciences.

Presence of TTV DNA in serum, liver and peripheral blood mononuclear cells from patients with chronic hepatitis

V. Carreño, I. Castillo, M. Pardo, 2000, Journal of viral hepatitis.

Randomized controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor for the treatment of chronic hepatitis c.

V. Carreño, S. Navas, J. Quiroga, 2000, Cytokine.

Histological damage in chronic hepatitis C is not related to the extent of infection in the liver.

J. Gosálvez, V. Carreño, F. Manzarbeitia, 1999, The American journal of pathology.

Patterns of immune responses to the host-encoded GOR and hepatitis C virus core-derived epitopes with relation to hepatitis C viremia, genotypes, and liver disease severity.

V. Carreño, S. Navas, J. Quiroga, 1996, The Journal of infectious diseases.

Immunoglobulin M antibody to hepatitis C virus core antigen: Correlations with viral replication, histological activity, and liver disease outcome

Changcai Wang, V. Carreño, J. van Binsbergen, 1995, Hepatology.

In situ detection of hepatitis C virus RNA in salivary glands.

J. Bartolomé, V. Carreño, F. Manzarbeitia, 2001, The American journal of pathology.

Association of HLA-DR genes with mild idiopathic adulthood biliary ductopenia

V. Carreño, J. Quiroga, M. Pardo, 2001, American Journal of Gastroenterology.

Comparative study between occult hepatitis C virus infection and chronic hepatitis C

V. Carreño, I. Castillo, M. Pardo, 2007, Journal of viral hepatitis.

Detection of hepatitis C virus replication by In situ hybridization in epithelial cells of anti–hepatitis C virus–positive patients with and without oral lichen planus

J. Bartolomé, V. Carreño, F. Manzarbeitia, 2000, Hepatology.

Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection

J. Bartolomé, V. Carreño, I. Castillo, 2007, Journal of medical virology.

In vitro effect of amantadine and interferon alpha-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients.

V. Carreño, M. Rico, S. Navas, 1999, Antiviral research.

Hepatitis C virus replicates in sweat glands and is released into sweat in patients with chronic hepatitis C

J. Bartolomé, V. Carreño, P. Lázaro, 2002, Journal of medical virology.

Detection of hepatitis C virus RNA and core protein in keratinocytes from patients with cutaneous lichen planus and chronic hepatitis C.

J. Bartolomé, V. Carreño, P. Lázaro, 2002, The Journal of investigative dermatology.

Fluorescent “in situ” hybridization of hepatitis C virus RNA in peripheral blood mononuclear cells from patients with chronic hepatitis C

J. Bartolomé, V. Carreño, S. Navas, 2000, Journal of medical virology.

Sequence of non-structural regions 3 and 5 of hepatitis C virus genomes from Spanish patients: existence of a predominant variant related to type 1b.

J. Bartolomé, V. Carreño, I. Castillo, 1995, The Journal of general virology.

Decreased nitric oxide production in chronic viral hepatitis B and C

J. Bartolomé, V. Carreño, A. López-Farré, 1997, Journal of medical virology.

Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony‐stimulating factor plus recombinant interferon‐alpha

V. Carreño, S. Navas, I. Castillo, 1995, Journal of medical virology.

Evidence of subtype-specific antibodies to antigenic epitopes in the NS5 region of hepatitis C virus in the circulation of patients with chronic hepatitis C.

J. Bartolomé, V. Carreño, I. Castillo, 1994, Clinical and diagnostic laboratory immunology.

A pilot study of recombinant interleukin‐2 for treatment of chronic hepatitis C

V. Carreño, I. Castillo, A. Fernandez-Flores, 1997, Hepatology.

Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients.

V. Carreño, S. Navas, J. Quiroga, 1998, Cytokine.

Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection

J. Bartolomé, V. Carreño, I. Castillo, 2003, Journal of medical virology.

Current therapy of chronic hepatitis B.

J. Bartolomé, V. Carreño, M. Pardo, 2007, Archives of medical research.

Risks and Benefits of Interferon-α in the Treatment of Hepatitis

V. Carreño, E. Marriott, J. Quiroga, 1995 .

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B.

P. Marcellin, S. Zeuzem, M. Diago, 2000, Journal of hepatology.

Extended follow-up of anti-HBe-positive patients with chronic hepatitis B retreated with ribavirin and interferon-alpha.

V. Carreño, M. Rico, J. Quiroga, 2001, Antiviral research.

Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) Can Coinfect the Same Hepatocyte in the Liver of Patients with Chronic HCV and Occult HBV Infection

J. Bartolomé, V. Carreño, I. Castillo, 2005, Journal of Virology.

Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody–positive patients

V. Carreño, F. Manzarbeitia, J. Quiroga, 2000, Hepatology.

Lack of efficacy of inosine pranobex in the treatment of chronic hepatitis C.

V. Carreño, M. Pardo, 1994, Journal of hepatology.

TT virus detection in oral lichen planus lesions

J. Bartolomé, M. Pardo, J. Arrieta, 2001, Journal of medical virology.

Impaired interferon induction of human MxA protein in chronic hepatitis B virus infection

V. Carreño, J. Quiroga, M. Pardo, 1997, Journal of medical virology.

Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.

D. Subirá, S. Castañón, V. Carreño, 2001, Hepatology.

Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.

J. Jimenez-Heffernan, J. Bartolomé, V. Carreño, 2004, The Journal of infectious diseases.

Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum

J. Bartolomé, V. Carreño, I. Castillo, 2004, Journal of medical virology.

Effect of anti‐viral therapy for occult hepatitis C virus infection

V. Carreño, I. Castillo, M. Pardo, 2006, Alimentary pharmacology & therapeutics.

Quantitation of hepatitis C virus in liver and peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection

G. Colucci, V. Carreño, S. Navas, 1998, Journal of medical virology.

Percentage of hepatitis C virus-infected hepatocytes is a better predictor of response than serum viremia levels.

J. Bartolomé, V. Carreño, M. Pardo, 2005, The Journal of molecular diagnostics : JMD.

Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection

V. Carreño, I. Castillo, M. Pardo, 2005, Gut.

Retreatment of chronic hepatitis C virus infection

V. Carreño, E. Marriott, J. Quiroga, 1994, The Lancet.

GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C, and D.

V. Carreño, A. Madejón, M. Pardo, 1997, Gastroenterology.

Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha.

V. Carreño, J. Quiroga, M. Pardo, 1994, Digestive diseases and sciences.

Modulation by biologic response modifiers of hepatitis C virus antigen-independent cytokine secretion in blood mononuclear cells.

V. Carreño, S. Navas, J. Quiroga, 1999, Cytokine.

Comparison of hepatitis C virus RNA detection in plasma, whole blood and peripheral blood mononuclear cells of patients with occult hepatitis C virus infection.

J. Bartolomé, V. Carreño, I. Castillo, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Combined Hepatitis C Virus (HCV) Antigen-Antibody Detection Assay Does Not Improve Diagnosis for Seronegative Individuals with Occult HCV Infection

V. Carreño, I. Castillo, J. Quiroga, 2006, Journal of Clinical Microbiology.

The role of genomic and antigenomic HCV‐RNA strands as predictive factors of response to pegylated interferon plus ribavirin therapy

V. Carreño, I. Castillo, J. Quiroga, 2007, Alimentary pharmacology & therapeutics.

LIVER Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection

I. Castillo, M. Pardo, J. Bartolomé, 2005 .

Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.

J. Bartolomé, V. Carreño, I. Castillo, 2006, The Journal of infectious diseases.

Immunoglobulin M antibody to hepatitis C virus core antigen: Correlations with viral replication, histological activity, and liver disease outcome

Changcai Wang, V. Carreño, J. van Binsbergen, 1995, Hepatology.

Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.

V. Carreño, S. Navas, I. Castillo, 1994, The Journal of infectious diseases.

Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection

J. Bartolomé, V. Carreño, I. Castillo, 2005, Gut.